Related Experiment Video

Updated: May 28, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Heart failure and development of type 2 diabetes mellitus]

Juana Antonia Flores-Le-Roux1, David Benaiges Boix, Juan Pedro-Botet

  • 1Servicio de Endocrinología, Hospital del Mar, Barcelona, España.

Medicina Clinica
|October 15, 2011
PubMed

Insights

Heart failure and type 2 diabetes often coexist. This review explores how heart failure may increase diabetes risk through mechanisms like insulin resistance, offering insights into managing these intertwined chronic conditions.

Area of Science:

  • Cardiology and Endocrinology
  • Metabolic Diseases
  • Clinical Research

Context:

  • Heart failure (HF) and type 2 diabetes mellitus (T2DM) are prevalent chronic conditions frequently observed together.
  • T2DM is an established risk factor for HF development and poorer prognosis.
  • The association of HF with increased diabetes incidence is less understood, necessitating further investigation into underlying mechanisms.

Purpose:

  • To review existing literature on the relationship between heart failure, insulin resistance, and the development of type 2 diabetes.
  • To explore potential pathophysiological mechanisms linking HF and T2DM.
  • To synthesize current knowledge on this bidirectional association.

Summary:

  • This literature review examines studies investigating the link between heart failure, insulin resistance, and type 2 diabetes.
  • Potential mechanisms discussed include sympathetic nervous system overactivity, elevated free fatty acid levels, and adiponectin resistance.
  • The review highlights the complex interplay and shared pathways between these two conditions.

Impact:

  • Provides a comprehensive overview of the current understanding of HF's role in T2DM development.
  • Identifies key pathophysiological mechanisms that may mediate this association.
  • Informs future research directions and clinical strategies for managing patients with comorbid HF and diabetes.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...